Muscle scans may reveal hidden death risk in ICU patients

NCT ID NCT07483710

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Saint Etienne Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study looks at whether muscle measurements from a CT scan taken when a patient is admitted to the ICU for septic shock can predict their risk of dying within 3 months after leaving the ICU. Researchers will analyze muscle size, density, and fat content from the scan and compare it to survival. The goal is to find a simple way to identify high-risk patients early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify high-risk septic shock patients earlier using a simple CT scan, potentially guiding more aggressive care.
What could go wrong: This is an observational study, not a treatment trial. It only looks for a link between muscle measures and death risk, so it cannot prove cause or improve outcomes directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPTIC SHOCK

Contacts and locations

Locations

AP HM, Hôpital La Timone
NOT_YET_RECRUITING

Marseille, 13385, France
Centre Hospitalier Universitaire de Saint-Etienne
RECRUITING

Saint-Etienne, 42055, France
Clinique Mutualiste
NOT_YET_RECRUITING

Saint-Etienne, 42000, France
Hospices Civils de Lyon
NOT_YET_RECRUITING

Lyon, 69000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.